Stock Quotes in this Article: CDXS, KERX, OREX, PSTI

WINDERMERE, Fla. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

>>5 Stocks Everyone Hates -- But You Should Love

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at several biotech stocks under $5 that are making large moves to the upside today.

 

Pluristem Therapeutics

Pluristem Therapeutics (PSTI) is a bio-therapeutics Company dedicated to the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. This stock is trading up 12.5% to $4.72 in recent trading.

Today’s Range: $4.51-$4.90

52-Week Range: $1.98-$5.00

Volume: 3 million

Three-Month Average Volume: 840,916

>>5 Technical Trades Under $5

Shares of PSTI are ripping higher today after the company said a third critically ill patient was successfully treated with its Placental eXpanded cells under compassionate use. The company said the outcome of its recent success with PLX cells suggest it may have significant potential to treat a range of indications of bone marrow diseases.

From a technical perspective, PSTI is gapping up big here with monster volume. This move is quickly pushing PSTI within range of triggering a major breakout trade. That trade will hit once PSTI takes out some near-term overhead resistance and its 52-week high at $5 with high volume.

Traders should now look for long-biased trades in PSTI once it sustains a move or close above $5 with volume that’s near or above 840,916 shares. If that breakout triggers soon, then PSTI will have a great chance of hitting $6 to $7 in the near future. Traders should use $4.50 as near-term support if PSTI can hold this gap and potentially breakout soon. Any high-volume move below $4.50 could send PSTI back towards $4.25 to $4, before it possibly sets up again to attempt the breakout.

Orexigen Therapeutics

Orexigen Therapeutics (OREX) is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. This stock is trading up 7.6% to $4.95 in recent trading.

Today’s Range: $4.65-$5.14

52-Week Range: $1.26-$7.73

Volume: 2.9 million

Three-Month Average Volume: 4.1 million

Shares of OREX are ripping higher today in front of its presentation at an investor conference on Wednesday, and after it released related information about its ongoing drug studies ahead of the meeting.

>>5 Rocket Stocks Worth Buying This Week

From a technical perspective, OREX is bouncing sharply here right off some near-term support at $4.50 with decent volume. This move is quickly pushing OREX within range of triggering a major breakout trade. That trade will hit once OREX clears some near-term overhead resistance at $4.85, and then once it takes out its 50-day moving average of $5.11 with high volume. At last check, OREX has hit an intraday high of $5.14 and volume is about 1 million shares below its three-month average action of 4,075,770 shares.

Traders should now look for long-biased trades in OREX once it sustains a move or close above $4.85 to $5.11 with volume that’s near or above 4.1 million shares. If that breakout triggers soon, then OREX has a great chance of heading north of $6, and possibly tagging its July high of $7.73. Traders should key off of $4.50 to $4.30 as support zones if you buy off weakness.

Codexis

Codexis (CDXS) is a developer of proprietary biocatalysts, which are enzymes or microbes that initiate or accelerate chemical reactions. This stock is trading up 8.1% at $2.3 in recent trading.

Today’s Range: $2.19-$2.47

52-Week Range: $2.01-$6.26

Volume: 161,000

Three-Month Average Volume: 139,955

>>5 Stocks With Big Insider Buying

From a technical perspective, CDXS is ripping higher here off some near-term support at $2.20 with above average volume. This move is coming after CDXS recently plunged from $4 to a low of $2.01. During that slide lower, shares of CDXS were consistently making lower highs and lower lows, which is bearish technical price action. That said, CDXS has now rebounded off its recent low and it’s quickly approaching a near-term breakout trade. That trade will hit once CDXS takes out some near-term overhead resistance at $2.55 with high volume.

Traders should now look for long-biased trades in CDXS once it sustains a move or close above $2.55 with volume that’s near or above 139,955 shares. If that breakout triggers soon, then CDXS will have a great chance of re-testing and possibly taking out its 50-day moving average of $3.08.

Keryx Biopharmaceuticals

Keryx Biopharmaceuticals (KERX) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease. This stock is trading up 4.4% at $2.14 in recent trading.

Today’s Range: $2.04-$2.17

52-Week Range: $1.28-$5.19

Volume: 1.2 million

Three-Month Average Volume: 1.15 million

Shares of KERX are moving notably higher today in front of its upcoming presentation at the Stifel Nicolaus 2012 Healthcare Conference on Thursday. The company will also be presenting at Rodman & Renshaw’s Annual Global Investment Conference on Sept. 10 and at the UBS Global Life Sciences Conference on Sept. 20.

>>5 Stocks Poised for Big Breakouts

From a technical perspective, KERX is moving higher here right near its 50-day moving average of $1.95 with above average volume. This move is quickly pushing KERX within range of triggering a major breakout trade. That trade will hit once KERX takes out some near-term overhead resistance levels at $2.22 to $2.34, and then its 200-day moving average of $2.44 with high volume.

Traders should now look for long-biased trades in KERX once it sustains a move or close above those levels with volume that’s near or above 1,154,840 share. If that breakout triggers soon, then KERX will have a great chance of getting into a previous gap down zone that started above $5.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.


RELATED LINKS:







Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to Beconequity.com and maintains the website Maddmoney.net, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.